Search hospitals > Florida > Fort Lauderdale

Broward Health Medical Center

Claim this profile
Fort Lauderdale, Florida 33316
Global Leader in Leukemia
Global Leader in Cancer
Conducts research for Breast Cancer
Conducts research for Lymphoma
Conducts research for Tumors
244 reported clinical trials
8 medical researchers
Photo of Broward Health Medical Center in Fort LauderdalePhoto of Broward Health Medical Center in Fort Lauderdale

Summary

Broward Health Medical Center is a medical facility located in Fort Lauderdale, Florida. This center is recognized for care of Leukemia, Cancer, Breast Cancer, Lymphoma, Tumors and other specialties. Broward Health Medical Center is involved with conducting 244 clinical trials across 404 conditions. There are 8 research doctors associated with this hospital, such as Hector M. Rodriguez-Cortes, Brian Slomovitz, Shannon B. Keating, and Ahmed Osman, MD.

Area of expertise

1Leukemia
Global Leader
Broward Health Medical Center has run 47 trials for Leukemia. Some of their research focus areas include:
Stage II
CD5 positive
Stage III
2Cancer
Global Leader
Broward Health Medical Center has run 37 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage I

Top PIs

Clinical Trials running at Broward Health Medical Center

Breast Cancer
Cancer
Osteosarcoma
Germ Cell Tumors
Rhabdomyosarcoma
Endometrial Cancer
Ovarian Tumors
Solid Tumors
Squamous Cell Carcinoma
Non-Hodgkin's Lymphoma
Image of trial facility.

Carvedilol

for Preventing Heart Problems in HER2 Positive Breast Cancer

This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Image of trial facility.

Omitting Radiation Therapy

for Breast Cancer

The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Pembrolizumab

for Triple-Negative Breast Cancer

The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Broward Health Medical Center?
Broward Health Medical Center is a medical facility located in Fort Lauderdale, Florida. This center is recognized for care of Leukemia, Cancer, Breast Cancer, Lymphoma, Tumors and other specialties. Broward Health Medical Center is involved with conducting 244 clinical trials across 404 conditions. There are 8 research doctors associated with this hospital, such as Hector M. Rodriguez-Cortes, Brian Slomovitz, Shannon B. Keating, and Ahmed Osman, MD.